Showing results (341-350 of 389) with videos related to

Sort By:
Pageof 39
Neurology|August 1, 1993
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two womenC H Waters, H Takahashi, K C Wilhelmsen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1991
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomographyD Eidelberg, V Dhawan, J R Moeller, et al.
Journal of Neurochemistry|June 20, 2001
Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivoM Neystat, M Rzhetskaya, T F Oo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1996
Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptoticT F Oo, R Blazeski, S M Harrison, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's diseaseJ G de Yebenes, S Fahn, S Lovelle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
Association of a missense change in the D2 dopamine receptor with myoclonus dystoniaC Klein, M F Brin, P Kramer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studiesD Eidelberg, J R Moeller, V Dhawan, et al.
Neurology|April 24, 2002
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutationsK Hedrich, K Marder, J Harris, et al.
Neurology|June 25, 2003
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind studyC T Trott, S Fahn, P Greene, et al.
Archives of Neurology|June 1, 1995
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study GroupM P McDermott, J Jankovic, J Carter, et al.
Pageof 39